We correlated FKBP12 and MDM2 expression to patient clinicopathologic characteristics such as age at diagnosis, tumor size, histologic grade, lymph-node metastatic status, NPI, proliferation rate of breast cancer cells (Index of MIB-1), ER, PR, HER2, and molecular subtype. This evidence concerns the gene MDM2 and breast cancer.